1 |
LIU M L, REN T L, LIN Z, et al. Upregulated miR-146a expression in peripheral blood relates to Th17 and Treg imbalance in elder rheumatoid arthritis patients[J]. Lifestyle Genom, 2022, 15(3): 98-106.
|
2 |
雷海桃, 田雪梅, 金芳全. 细胞因子信号转导抑制因子与类风湿关节炎的相关性研究进展[J]. 上海交通大学学报(医学版), 2022, 42(7): 945-951.
|
|
LEI H T, TIAN X M, JIN F Q. Advances in the correlation between cytokine signal transduction inhibitors and rheumatoid arthritis[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 945-951.
|
3 |
ISLAM Z U, BANEEN U, KHALIQ T, et al. Association analysis of miRNA-146a and miRNA-499 polymorphisms with rheumatoid arthritis: a case-control and trio-family study[J]. Clin Exp Med, 2023, 23(5): 1667-1675.
|
4 |
ALI Y, KHAN A, AKHTAR M, et al. Exploring the associations and molecular impacts of miR-146a/rs2910164 and miR-196a2/rs185070757 with rheumatoid arthritis in a Pakistani population[J]. Lifestyle Genom, 2023, 16(1): 139-150.
|
5 |
ZHANG L L, WU X X, WANG X F, et al. Genetic variant in microRNA-146a gene is associated with risk of rheumatoid arthritis[J]. Ann Med, 2021, 53(1): 824-829.
|
6 |
李博. miR-146a在类风湿关节炎发病机制中的作用及其与中医体质的相关性研究[D]. 广州: 南方医科大学, 2020.
|
|
LI B. miR-146a in the pathogenesis of rheumatoid arthritis and its correlation with traditional Chinese medical constitutions[D]. Guangzhou: Southern Medical University, 2020.
|
7 |
李博, 胡秋侠, 谭锦辉, 等. 类风湿关节炎患者中医体质分布及miR-146a表达[J]. 中国中西医结合杂志, 2019, 39(9): 1045-1049.
|
|
LI B, HU Q X, TAN J H, et al. Chinese medical constitution and expression of miR-146a in rheumatoid arthritis patients[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2019, 39(9): 1045-1049.
|
8 |
胡秋侠, 李博, 佘若男, 等. miR-146a rs2910164位点多态性与类风湿关节炎病情活动的相关性[J]. 中华医学遗传学杂志, 2019, 36(5): 505-507.
|
|
HU Q X, LI B, SHE R N, et al. Association of polymorphisms of miR-146a rs2910164 locus with clinical features of rheumatoid arthritis[J]. Chinese Journal of Medical Genetics, 2019, 36(5): 505-507.
|
9 |
李博, 胡秋侠, 谭锦辉, 等. 类风湿关节炎中miR-146a多态性与临床表现及血清中肿瘤坏死因子α水平之间的相关性[J]. 中国现代应用药学, 2019, 36(4): 471-474.
|
|
LI B, HU Q X, TAN J H, et al. miR-146a rs2910164 polymorphism correlates with extraarticular manifestations and the serum TNF-α level in patients with rheumatoid arthritis[J]. Chinese Journal of Modern Applied Pharmacy, 2019, 36(4): 471-474.
|
10 |
HAN R F, GAO J, WANG L M, et al. microRNA-146a negatively regulates inflammation via the IRAK1/TRAF6/NF-κB signaling pathway in dry eye[J]. Sci Rep, 2023, 13(1): 11192.
|
11 |
ZHANG Y S, LIANG X J, BAO X F, et al. Toll-like receptor 4 (TLR4) inhibitors: current research and prospective[J]. Eur J Med Chem, 2022, 235: 114291.
|
12 |
PENG Y Q, CHEN B Q, SHENG X W, et al. The genetic association between TLR-1, -2, -4, and -6 gene polymorphisms and rheumatoid arthritis susceptibility in a Chinese Han population[J]. Genet Test Mol Biomarkers, 2022, 26(3): 140-145.
|
13 |
KONG L L, WANG L F, ZHAO Q, et al. Rhodojaponin Ⅱ inhibits TNF-α-induced inflammatory cytokine secretion in MH7A human rheumatoid arthritis fibroblast-like synoviocytes[J]. J Biochem Mol Toxicol, 2020, 34(10): e22551.
|
14 |
GUO F, WU S. Antisense IRAK-1 oligonucleotide blocks activation of NF-kappa B and AP-1 induced by IL-18[J]. Immunopharmacology, 2000, 49(3): 241-246.
|
15 |
GILYAZOVA I, ASADULLINA D, KAGIROVA E, et al. miRNA-146a: a key player in immunity and diseases[J]. Int J Mol Sci, 2023, 24(16): 12767.
|
16 |
TAVASOLIAN F, HOSSEINI A Z, SOUDI S, et al. miRNA-146a improves immunomodulatory effects of MSC-derived exosomes in rheumatoid arthritis[J]. Curr Gene Ther, 2020, 20(4): 297-312.
|
17 |
KONG R N, GAO J, JI L M, et al. Iguratimod ameliorates rheumatoid arthritis progression through regulating miR-146a mediated IRAK1 expression and TRAF6/JNK1 pathway: an in vivo and in vitro study[J]. Clin Exp Rheumatol, 2021, 39(2): 289-303.
|
18 |
MORTAZAVI-JAHROMI S S, AHMADZADEH A, REZAIEYAZDI Z, et al. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients[J]. Immunopharmacol Immunotoxicol, 2020, 42(3): 228-236.
|
19 |
张晓苹, 李茹, 王世瑶, 等. 微小RNA-146a对类风湿关节炎患者滑膜成纤维细胞抑制作用的研究[J]. 中华风湿病学杂志, 2010, 14(4): 220-222.
|
|
ZHANG X P, LI R, WANG S Y, et al. The inhibitory effect of miR-146a on rheumatoid arthritis synovial fibroblast[J]. Chinese Journal of Rheumatology, 2010, 14(4): 220-222.
|
20 |
胡秋侠, 李博, 吴系美, 等. 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗类风湿关节炎疗效及与尿沉渣中miR146a表达的相关性[J]. 中国药师, 2018, 21(8): 1413-1415.
|
|
HU Q X, LI B, WU X M, et al. Efficacy of recombinant human tumor necrosis factor-α receptor Ⅱ: Fc in the treatment of rheumatoid arthritis and its correlation with miR-146a expression in urinary sediment[J]. China Pharmacist, 2018, 21(8): 1413-1415.
|